Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.
about
Animal models of chronic pain: Advances and challenges for clinical translation.[EXPRESS] Epac and Nociceptor Sensitization.Persistent Electrical Activity in Primary Nociceptors after Spinal Cord Injury Is Maintained by Scaffolded Adenylyl Cyclase and Protein Kinase A and Is Associated with Altered Adenylyl Cyclase Regulation.Adenosine-A1 receptor agonist induced hyperalgesic priming type II.Opioid-induced Loss of Local Anesthetic Potency in the Rat Sciatic Nerve.SDF1-CXCR4 Signaling Contributes to the Transition from Acute to Chronic Pain State.Gi-protein-coupled 5-HT1B/D receptor agonist sumatriptan induces type I hyperalgesic priming.Sexual Dimorphism in a Reciprocal Interaction of Ryanodine and IP3 Receptors in the Induction of Hyperalgesic Priming.Hyperalgesic priming (type II) induced by repeated opioid exposure: maintenance mechanisms.Sustained Morphine Administration Induces TRPM8-Dependent Cold Hyperalgesia.Marked sexual dimorphism in 5-HT1 receptors mediating pronociceptive effects of sumatriptan.Translational Control Mechanisms in Persistent Pain.Inhibition of β-ARK1 Ameliorates Morphine-induced Tolerance and Hyperalgesia Via Modulating the Activity of Spinal NMDA Receptors.The dark side of opioids in pain management: basic science explains clinical observation.Fentanyl Induces Rapid Onset Hyperalgesic Priming: Type I at Peripheral and Type II at Central Nociceptor Terminals.Inhibitory Gi/O-coupled receptors in somatosensory neurons: Potential therapeutic targets for novel analgesics.Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor.
P2860
Q30249165-37A851E2-7D94-4239-9D3F-AAEEB9DB69A6Q33866295-7F833E93-CEF3-4C68-B3C5-3C37D68916CBQ36534368-5714E171-6697-42E4-84D0-4F29159FAEA4Q37308329-F5125C83-62E3-419C-9417-F7657BBCECA9Q39590831-5FB84684-853F-4C04-BAC2-4C82070F17A2Q39891334-79743E4E-C925-4847-9523-83CDAA69FAF5Q41300169-1B6CB41B-F443-456A-AC44-9E980479063EQ42318088-E0F8FFAC-074D-45EC-980E-57FAFA70219CQ44344074-23A4FCF8-5A0F-4A60-8A9E-C50842C49EF4Q44914027-8BEF67C2-1719-4C84-AD58-A1398918F74EQ46160367-3231EABE-C72C-4282-95E2-29CC44F863F3Q47220043-BA06639E-DB25-48D3-B519-A92CA0D6406FQ47702437-E6380B28-8765-4404-82CA-6083985821C8Q49384858-0C34C1CD-B906-4BDF-89F8-A556EEDFB05FQ50066450-544105E8-EAFF-4982-AE92-040413CD1D3DQ52630403-82BF3C0A-A667-4614-AEF0-FEDB2DEE5844Q55248528-83260510-CAF8-473E-AFF1-CE0742E3B7A6
P2860
Repeated Mu-Opioid Exposure Induces a Novel Form of the Hyperalgesic Priming Model for Transition to Chronic Pain.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Repeated Mu-Opioid Exposure In ...... or Transition to Chronic Pain.
@ast
Repeated Mu-Opioid Exposure In ...... or Transition to Chronic Pain.
@en
type
label
Repeated Mu-Opioid Exposure In ...... or Transition to Chronic Pain.
@ast
Repeated Mu-Opioid Exposure In ...... or Transition to Chronic Pain.
@en
prefLabel
Repeated Mu-Opioid Exposure In ...... or Transition to Chronic Pain.
@ast
Repeated Mu-Opioid Exposure In ...... or Transition to Chronic Pain.
@en
P2860
P1476
Repeated Mu-Opioid Exposure In ...... or Transition to Chronic Pain.
@en
P2093
Luiz F Ferrari
P2860
P304
12502-12517
P356
10.1523/JNEUROSCI.1673-15.2015
P407
P577
2015-09-01T00:00:00Z